title: Alterations in synaptic curvature in the dentate gyrus following induction of long-term potentiation, long-term depression, and treatment with the N-methyl-D-aspartate receptor antagonist CPP.
abstract: Alterations in curvature of the post synaptic density (PSD) and apposition zone (AZ), are believed to play an important role in determining synaptic efficacy. In the present study we have examined curvature of PSDs and AZs 24 h following homosynaptic long-term potentiation (LTP), and heterosynaptic long-term depression (LTD) in vivo, in awake adult rats. High frequency stimulation (HFS) applied to the medial perforant path to the dentate gyrus induced LTP while HFS stimulation of the lateral perforant path induced LTD in the middle molecular layer of the dentate gyrus (DG). Curvature changes were analysed in this area using three dimensional (3-D) reconstructions of electron microscope images of ultrathin serial sections. Very large and significant changes in 3-D measurements of AZ and PSD curvature occurred 24 h following both LTP and LTD, with a flattening of the normal concavity of mushroom spine heads and a change to convexity for thin spines. An N-methyl-D-aspartate (NMDA) receptor antagonist CPP (3-[(R)-2-Carboxypiperazin-4-yl]-propyl-1-phosphonic acid) blocked the changes in curvature of mushroom and thin spine PSDs and apposition zones, actually increasing the concavity of mushroom spines as the spine engulfed the presynaptic bouton. In order to establish whether these changes resulted from the effect of the NMDA antagonist or from its coincidence with synaptic activation during testing we examined the effects of CPP alone on PSD and apposition zone curvature. It was found that CPP alone also caused a small decrease in curvature of both PSD and apposition zone of mushroom and thin spines.
authors.affiliation: Department of Life Sciences, The Open University, Milton Keynes, UK.
authors.forename: N I
authors.initials: NI
authors.lastname: Medvedev
authors.forename: V I
authors.initials: VI
authors.lastname: Popov
authors.forename: G
authors.initials: G
authors.lastname: Dallérac
authors.forename: H A
authors.initials: HA
authors.lastname: Davies
authors.forename: S
authors.initials: S
authors.lastname: Laroche
authors.forename: I V
authors.initials: IV
authors.lastname: Kraev
authors.forename: J J
authors.initials: JJ
authors.lastname: Rodriguez Arellano
authors.forename: V
authors.initials: V
authors.lastname: Doyère
authors.forename: M G
authors.initials: MG
authors.lastname: Stewart
mesh_terms: D000818:Animals; D049229:Dendritic Spines / Q000187:drug effects / Q000648:ultrastructure; D018891:Dentate Gyrus / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D017774:Long-Term Potentiation; D036881:Long-Term Synaptic Depression; D008297:Male; D010879:Piperazines / Q000494:pharmacology*; D057907:Post-Synaptic Density / Q000187:drug effects; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D013569:Synapses / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure
chemical_list: D010879:Piperazines; D016194:Receptors, N-Methyl-D-Aspartate; C050592:3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid